Change in Ownership of Klippan AB
September 27, 2005 03:09 ET
|
Klippan
KLIPPAN, Sweden, Sept. 27, 2005 (PRIMEZONE) -- Jan Bernander and Stefan Lersten have sold 1 million shares in KLIPPAN AB to Nove Capital and associated companies. After this, Weland AB owns some 17...
Tele2 Uses Its Own Network to Offer Fixed Telephony in Denmark
September 27, 2005 03:05 ET
|
Tele2
STOCKHOLM, Sweden, Sept. 27, 2005 (PRIMEZONE) -- Tele2 AB, ("Tele2"), (Stockholmsborsen:TEL2A) and (Stockholmsborsen:TEL2B), the leading alternative pan-European telecommunications company, today...
Statkraft - More eco-friendly power from Europe's largest land-based wind farm
September 27, 2005 03:00 ET
|
Statkraft AS
"We are now seeing the results of our considerable investment in new environment-friendly generating capacity," says Statkraft CEO Bård Mikkelsen. "Smøla wind farm is Europe's largest land-based wind...
Statkraft - Europas største vindpark på land åpnes i dag
September 27, 2005 03:00 ET
|
Statkraft AS
- Vi ser nå omfattende resultater av vår offensive satsing på ny, miljøvennlig energi. Smøla vindpark er Europas største vindpark på land. Den er nesten tre ganger så stor som Hitra vindpark, som var...
Confirmed Favorable Safety Profile for Active Biotech's Oral MS Drug
September 27, 2005 02:37 ET
|
Active Biotech
STOCKHOLM, Sweden, Sept. 27, 2005 (PRIMEZONE) -- The safety data from Active Biotech's (Stockholm:ACTI.ST) recently concluded clinical phase II safety study shows that laquinimod, a novel oral...
Skanska to Build Post Office Terminal in Czech Republic for SEK 366 M
September 27, 2005 02:35 ET
|
Skanska
STOCKHOLM, Sweden, Sept. 27, 2005 (PRIMEZONE) -- Skanska has secured the contract to build a post-office terminal in Brno in the Czech Republic. The contract is worth CZK 1.2 billion, approximately...
Fördelaktig säkerhetsprofil bekräftad för Active Biotechs orala MS-läkemedel
September 27, 2005 02:30 ET
|
Active Biotech
Syftet med studien var att undersöka säkerheten för patienten då laquinimod administreras oralt, vid en högre dos (0.9 mg/dag) än den dos som i tidigare studier visat sig vara effektiv i att minska...
Confirmed favorable safety profile for Active Biotech's oral MS drug
September 27, 2005 02:30 ET
|
Active Biotech
The aim of the study was to investigate the safety of orally administered laquinimod at a higher dose (0.9 mg/day) than the dose previously shown to be effective in reducing the number of active brain...
Nidec to Open IR Office in U.K.
September 27, 2005 02:30 ET
|
Nidec Corporation
KYOTO, Japan, Sept. 27, 2005 (PRIMEZONE) -- Nidec Corporation ("Nidec") (NYSE:NJ) announced today that it is opening a new office in London on October 1, 2005, which engages in investor relations...
Volvo Launches World's First CO2-Free Automotive Plant
September 27, 2005 02:19 ET
|
Volvo
GOTEBORG, Sweden, Sept. 27, 2005 (PRIMEZONE) -- AB Volvo has decided to make Volvo Trucks' plant in Tuve the world's first CO2-free automotive plant. As a result of investments in wind power and...
- September 27, 2024 20:17 ET Hong Kong Social Enterprise Rhys Workshop participated in International Home Care and Rehabilitation Exhibition (H.C.R.) for the first time promoting healthy clothing for the elderly and disabled people
- September 27, 2024 19:00 ET Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Metagenomi Inc.